Welcome to Esurgi

Esurgi is a biotech company committed to improving relationships between healthcare providers and their patients by offering products that are interactive, automated and informative.

Learn Who We Are

Product Offering

Our products are very Simple to Administer, Efficiently improve quality of life, detecting individual biomechanical concerns earlier and automating repeatable tasks. As a result, our Flagship product, the Biostabilizer is a Biofeedback Unit poised to revolutionize physical therapy.

Find Out More

Join Our Community

At Esurgi, we believe that forming dynamic relationships with our clients is essential to offering world class products and services. Staying true to our ethos, we aim to foster a community centered on developing innovative solutions to big picture problems.

Get Involved

Persistent and Pernicious: Postpartum Lower Back Pain

by Smriti Haria | June 6, 2021 | Biostabilizer, Low Back Pain, Medical Officers | 0 Comments

Pregnancy brings with it a slew of side effects, child aside, including morning sickness, swollen feet, cravings, and of course, back pain. 50-80% of pregnant women report lower back pain (LBP), whilst one-third of them deem it a significant problem [1]. In...

Alzheimer’s Neuropathology: Neuroinflammation in Patients Exemplifies the Presence of Both a Neuronal and Immunological Response

by Sharen Singh | June 3, 2021 | Alzheimer's Disease, I. Issues, II. Roles, Medical Officers | 0 Comments

Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the neuronal compartment, but includes strong interactions with immunological mechanisms in the brain. Misfolded and aggregated proteins bind to pattern recognition receptors on...

Inspecting The Influences on Alzheimer’s Disease Development

by Marina Norfolk | May 31, 2021 | Alzheimer's Disease, Medical Officers | 0 Comments

Alzheimer’s disease (AD) is a chronic neurodegenerative disease that leads to gradual loss of function in motor skills and cognitive function of patients. As the most common type of dementia, Alzheimer’s impacts over 5 million Americans who are 65 and older, and this...

The Glymphatic System’s Potential Link to Alzheimers

by Sophie Gilbert | May 21, 2021 | Alzheimer's Disease, Medical Officers | 0 Comments

Current research on Alzheimer's Disease (AD) suggests that it is the abnormal build-up of proteins like amyloids, which deposit plaques in and around brain cells, that lead to degeneration of cognitive function. Until recently, there was no evidence for any...

Think Before You Eat: Diet and Alzheimer’s Disease

by Smriti Haria | May 20, 2021 | Alzheimer's Disease, IV. Others, Medical Officers, Prescribers | 0 Comments

According to the Mayo Clinic, around 5.8 million people over the age of 65 in the United States are diagnosed with Alzheimer’s Disease (AD) [1]. Neurons in the brain atrophy, leading to an impairment in thinking, cognitive and social skills. Additionally, AD is the...

The neuroprotective role of Hydrogen Sulfide in Alzheimer’s disease

by Gaganpreet Kaur | May 19, 2021 | Alzheimer's Disease | 0 Comments

Alzheimer's disease (AD), a neurodegenerative disease, is a leading cause of dementia. AD is characterised by microtubule-associated protein Tau hyperphosphorylation and β-amyloid peptides aggregates, which ultimately leads to the development of neurofibrillary...

An Audit of the Stages of Spinal Cord Injury Pathogenesis and their Relation to Secondary Medical Complications and Potential Chronicity in Patients

by Sharen Singh | May 4, 2021 | I. Issues, II. Roles, Medical Officers, Physical Therapy / Medicine and Rehabilitation, Prescribers, Prescription Support | 0 Comments

More than a decade ago, spinal-cord injury meant confinement to a wheelchair and a lifetime of medical comorbidity. The physician's armamentarium of treatments was very limited, and provision of care for individuals with spinal-cord injury was usually met with...

Who is at risk for ACL tears?: Musculoskeletal and Genetic Risk Factors

by Smriti Haria | April 29, 2021 | Anterior Cruciate Ligament Injury, Medical Officers, Physical Therapy / Medicine and Rehabilitation | 0 Comments

Anterior Cruciate Ligament (ACL) tears are by no means an injury foreign to athletes and the medical personnel who work with them, and they’re perhaps more common than you think: 1 in 3500 people in the United States report an ACL tear every year [1]! This frequency...

Do human mesenchymal stem cell derived exosomes have a potential therapeutic role in Alzheimer’s Disease?

by Gaganpreet Kaur | April 17, 2021 | Alzheimer's Disease | 0 Comments

Alzheimer’s disease (AD), a neurodegenerative disease, is the leading cause of dementia worldwide (1). Although the pathophysiology of AD is diverse, it is mainly characterized by hyperphosphorylation of tau protein, accumulation of beta-amyloid peptide (Aβ),...

Pathogenic Agents of Alzheimer’s Disease and Their Corresponding Pharmacotherapeutic Treatment Hypotheses

by Sharen Singh | April 16, 2021 | Alzheimer's Disease, I. Issues, II. Roles, Medical Officers, Physical Therapy / Medicine and Rehabilitation, Prescribers | 0 Comments

Alzheimer’s Disease (AD), the most common cause of dementia, is a progressive and fatal neurodegenerative disorder that primarily affects older adults. Though the definitive etiology of the disease is still to be uncovered, several characteristic features of the...